Fitzgerald Industries International, Inc. CA 15-3 protein 30-AC16S2

Description
Partially pure native Human CA 15-3 protein Background: CA 15-3 (Cancer Antigen 15-3) is breast tumor marker. Diagnostic tests measuring the MUC1- glycoprotein are FDA/EU approved including CA 15-3, CA 27-29 and Br assays. Reoccurrence detection of breast cancer by MUC-1 assay can preceed confirmation by radiological detection methods by 1-9 months.
Description
Partially pure native Human CA 15-3 protein Background: CA 15-3 (Cancer Antigen 15-3) is breast tumor marker. Diagnostic tests measuring the MUC1- glycoprotein are FDA/EU approved including CA 15-3, CA 27-29 and Br assays. Reoccurrence detection of breast cancer by MUC-1 assay can preceed confirmation by radiological detection methods by 1-9 months.

Suppliers

Company
Product
Description
Supplier Links
Fitzgerald Industries International, Inc.
Acton, MA, USA
CA 15-3 protein
30-AC16S2
CA 15-3 protein 30-AC16S2
Partially pure native Human CA 15-3 protein Background: CA 15-3 (Cancer Antigen 15-3) is breast tumor marker. Diagnostic tests measuring the MUC1- glycoprotein are FDA/EU approved including CA 15-3, CA 27-29 and Br assays. Reoccurrence detection of breast cancer by MUC-1 assay can preceed confirmation by radiological detection methods by 1-9 months.

Partially pure native Human CA 15-3 protein
Background:
CA 15-3 (Cancer Antigen 15-3) is breast tumor marker. Diagnostic tests measuring the MUC1- glycoprotein are FDA/EU approved including CA 15-3, CA 27-29 and Br assays. Reoccurrence detection of breast cancer by MUC-1 assay can preceed confirmation by radiological detection methods by 1-9 months.

Supplier's Site

Technical Specifications

  Fitzgerald Industries International, Inc.
Product Category Biological Materials
Product Number 30-AC16S2
Product Name CA 15-3 protein
Unlock Full Specs
to access all available technical data

Similar Products